Exclusive: A fast-track visa route for Nobel prize laureates and other award-winners in science, engineering, the humanities and medicine has failed to attract any applicants
Share
French doctor Didier Raoult is an author on one-third of the papers in a single journal. Alain Apaydin/Abaca/Sipa via AP Images
Journals singled out for favoritism
Feb. 25, 2021 , 10:05 AM
When Didier Raoult published several studies last year purporting to show the promise of the malaria drug hydroxychloroquine as a treatment for COVID-19, critics quickly denounced his methods. Raoult, a microbiologist at Aix-Marseille University, now faces disciplinary action by a French medical regulator, and the drug has largely been discredited as a COVID-19 treatment.
But some researchers had another concern: Raoult’s astonishingly prolific publication in the journal
New Microbes and New Infections, where some of Raoult’s collaborators serve as associate editors and editor-in-chief. Since the journal’s creation in 2013, Raoult’s name appeared on one-third of its 728 papers. Florian Naudet, a metascientist at the University of Rennes, wondered how common the pattern
Unity Park names honorees for 2021 cdispatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cdispatch.com Daily Mail and Mail on Sunday newspapers.